MEDICINA
Departamento
NewYork–Presbyterian Hospital
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de NewYork–Presbyterian Hospital (3)
2021
2020
-
Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study
Leukemia, Vol. 34, Núm. 8, pp. 2125-2137
2016
-
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma
Blood, Vol. 128, Núm. 9, pp. 1174-1180